STAMFORD, Conn., and SYDNEY, Australia, Oct. 30 /PRNewswire-FirstCall/ -- Novogen Limited advises the market that Dr. Graham Kelly, has now ceased his operational and executive functions with the Company and will continue to provide ongoing scientific services to the Novogen Group on a consultancy basis.
Novogen LimitedCONTACT: Christopher Naughton, Managing Director of Novogen Limited, +61(02) 9878 0088; or David Sheon, +1-202-518-6321, for Novogen Limited
Web site: http://www.novogen.com/